| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |